Cargando…
进展期非小细胞肺癌的首过法CT灌注可重复性研究
BACKGROUND AND OBJECTIVE: The aim of this study is to explore the reproducibility of volume-based quantitative measurement of non-small cell lung cancer (NSCLC) perfusion at 64-slice CT. METHODS: Fourteen patients with proved advanced NSCLC were enrolled in this dynamic frst pass volume-based CT per...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000689/ https://www.ncbi.nlm.nih.gov/pubmed/20677648 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.05.21 |
_version_ | 1783331815098941440 |
---|---|
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: The aim of this study is to explore the reproducibility of volume-based quantitative measurement of non-small cell lung cancer (NSCLC) perfusion at 64-slice CT. METHODS: Fourteen patients with proved advanced NSCLC were enrolled in this dynamic frst pass volume-based CT perfusion (CTP) study (8×5 mm collimation), and they underwent the second scan within 24 h. According to the longest diameters, those patients were classifed to ≤3 cm and >3 cm groups, and each group had 7 patients. Intraclass correlation coefcient (ICC) and Bland-Altman statistics were used to evaluate the reproducibility of CTP imaging. RESULTS: In both groups of advanced NSCLC, the reproducibility with BF, BV, and PS values were good (ICC >0.75 for all), but mean transit time (MT) values. For advanced NSCLC (≤3 cm), repeatability coefcient (RC) values with blood flow (BF), blood volume (BV), MT and permeability surface area product (PS) values were 56%, 45%, 114%, and 78%, respectively, and the 95% change intervals of RC were -39%-53%, -29%-62%, -83%-145%, and -57%-98%, respectively. For advanced NSCLC (>3 cm), those values were 46%, 30%, 59%, and 33%, respectively, and the 95% change intervals of RC were -48%-45%, -33%-26%, -54%-64%, and -18%-48%. CONCLUSION: Tere is greater reproducibility of tumor size >3 cm than that of ≤3 cm. BF and BV could be addressed for reliable clinical application in antiangiogenesis therapeutic monitoring with advanced NSCLC patients. |
format | Online Article Text |
id | pubmed-6000689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60006892018-07-06 进展期非小细胞肺癌的首过法CT灌注可重复性研究 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: The aim of this study is to explore the reproducibility of volume-based quantitative measurement of non-small cell lung cancer (NSCLC) perfusion at 64-slice CT. METHODS: Fourteen patients with proved advanced NSCLC were enrolled in this dynamic frst pass volume-based CT perfusion (CTP) study (8×5 mm collimation), and they underwent the second scan within 24 h. According to the longest diameters, those patients were classifed to ≤3 cm and >3 cm groups, and each group had 7 patients. Intraclass correlation coefcient (ICC) and Bland-Altman statistics were used to evaluate the reproducibility of CTP imaging. RESULTS: In both groups of advanced NSCLC, the reproducibility with BF, BV, and PS values were good (ICC >0.75 for all), but mean transit time (MT) values. For advanced NSCLC (≤3 cm), repeatability coefcient (RC) values with blood flow (BF), blood volume (BV), MT and permeability surface area product (PS) values were 56%, 45%, 114%, and 78%, respectively, and the 95% change intervals of RC were -39%-53%, -29%-62%, -83%-145%, and -57%-98%, respectively. For advanced NSCLC (>3 cm), those values were 46%, 30%, 59%, and 33%, respectively, and the 95% change intervals of RC were -48%-45%, -33%-26%, -54%-64%, and -18%-48%. CONCLUSION: Tere is greater reproducibility of tumor size >3 cm than that of ≤3 cm. BF and BV could be addressed for reliable clinical application in antiangiogenesis therapeutic monitoring with advanced NSCLC patients. 中国肺癌杂志编辑部 2010-05-20 /pmc/articles/PMC6000689/ /pubmed/20677648 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.05.21 Text en 版权所有©《中国肺癌杂志》编辑部2010 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 临床研究 进展期非小细胞肺癌的首过法CT灌注可重复性研究 |
title | 进展期非小细胞肺癌的首过法CT灌注可重复性研究 |
title_full | 进展期非小细胞肺癌的首过法CT灌注可重复性研究 |
title_fullStr | 进展期非小细胞肺癌的首过法CT灌注可重复性研究 |
title_full_unstemmed | 进展期非小细胞肺癌的首过法CT灌注可重复性研究 |
title_short | 进展期非小细胞肺癌的首过法CT灌注可重复性研究 |
title_sort | 进展期非小细胞肺癌的首过法ct灌注可重复性研究 |
topic | 临床研究 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000689/ https://www.ncbi.nlm.nih.gov/pubmed/20677648 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.05.21 |
work_keys_str_mv | AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū |